Details for Patent: 10,058,536
✉ Email this page to a colleague
Which drugs does patent 10,058,536 protect, and when does it expire?
Patent 10,058,536 protects MYRBETRIQ GRANULES and is included in one NDA.
Protection for MYRBETRIQ GRANULES has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirteen patent family members in thirteen countries.
Summary for Patent: 10,058,536
| Title: | Pharmaceutical composition containing mirabegron |
| Abstract: | To provide: (1) a modified release liquid (suspension) containing mirabegron, (2) a ready-to-suspend pharmaceutical composition containing mirabegron, and (3) a mirabegron-containing pharmaceutical composition that does not generate undissolved lumps, even when it is suspended at the time of use. The present invention relates to a pharmaceutical composition containing a complex of mirabegron or a pharmaceutically acceptable salt thereof with sodium polystyrene sulfonate. |
| Inventor(s): | Takae; Seiji (Tokyo, JP), Sakai; Toshiro (Tokyo, JP), Kasashima; Yuki (Tokyo, JP), Ansei; Yurina (Tokyo, JP), Kiyota; Tsuyoshi (Tokyo, JP) |
| Assignee: | ASTELLAS PHARMA INC. (Tokyo, JP) |
| Application Number: | 15/553,107 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,058,536
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apgdi | MYRBETRIQ GRANULES | mirabegron | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 213801-001 | Mar 25, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,058,536
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2015-073911 | Mar 31, 2015 |
| PCT Information | |||
| PCT Filed | March 31, 2016 | PCT Application Number: | PCT/JP2016/060745 |
| PCT Publication Date: | October 06, 2016 | PCT Publication Number: | WO2016/159267 |
International Family Members for US Patent 10,058,536
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Cyprus | 1122352 | ⤷ Try a Trial | |||
| Denmark | 3278801 | ⤷ Try a Trial | |||
| European Patent Office | 3278801 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
